CN102550541A - Organ vitrification freezing and preserving fluid - Google Patents

Organ vitrification freezing and preserving fluid Download PDF

Info

Publication number
CN102550541A
CN102550541A CN2010106013581A CN201010601358A CN102550541A CN 102550541 A CN102550541 A CN 102550541A CN 2010106013581 A CN2010106013581 A CN 2010106013581A CN 201010601358 A CN201010601358 A CN 201010601358A CN 102550541 A CN102550541 A CN 102550541A
Authority
CN
China
Prior art keywords
freezing
organ
preserving
organs
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010106013581A
Other languages
Chinese (zh)
Other versions
CN102550541B (en
Inventor
潘峰
刘迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201010601358.1A priority Critical patent/CN102550541B/en
Publication of CN102550541A publication Critical patent/CN102550541A/en
Application granted granted Critical
Publication of CN102550541B publication Critical patent/CN102550541B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to the field of medical organ preservation and more particularly discloses a vitrification freezing and preserving fluid for preserving organs for a long term. The organ vitrification freezing and preserving fluid is characterized by comprising dimethyl sulfoxide, acetamide, glycerol, ethylene glycol, propylene glycol, cane sugar, polyethylene glycol and the like, wherein the concentrations of the dimethyl sulfoxide, the acetamide, the glycerol, the ethylene glycol, the propylene glycol and the cane sugar are 0.1-6 mol/L; the concentration of the polyethylene glycol is 1-20 mmol/L; and the pH value is in a range from 5.0 to 8.0. By implementing the vitrification preserving fluid for preserving organs, provided by the invention, the preserving fluid is in a glassy state rather than forming ice crystal in the cooling and freezing process to protect the tissue morphology and structure completeness, completely suppresses energy metabolism of tissue cells under a freezing condition and recovers biological functions of organs after anabiosis. The organ vitrification freezing and preserving fluid, disclosed by the invention, can be used for freezing and preserving kidney and also can be further widely applied to freezing and preserving of other organs for a long term for scientific research and clinic application.

Description

The organ glass freezing is preserved liquid
Technical field
Kidney is the complicated organ of function in the human body, can only {in vitro} conservation under 4 ℃ of perfusion conditions maximum 50 hours.Will be for a long time even forever preserve kidney, must further reduce storage temperature, suppress histiocytic metabolic rate, even cellular metabolism is stopped fully.Kidney if can be preserved at suitable long period under refrigeration, transplants after when needed that the confession kidney employing of freezing preservation is the suitable means " recovery " again, will open up a brand-new prospect for clinical transplantation work.
Freezing and storing method is considered to realize the desirable approach of organ long preservation; Key of problem is that the organ volume is bigger; Ice crystal forms inside and outside in cooling and rewarming process, being difficult to overcome cell; Can not avoid simultaneously the damage of machinery, chemistry, osmotic pressure and biology aspect, so the frozen problem of larger volume organ is still unresolved so far.Vitrifying (Vitrification) is meant that liquid changes the solidification process of amorphous state (glassy state) into.Relation between the glassy solids molecule and the obviously difference of liquid nothing do not form ice crystal, thereby are a kind of desirable freezing preservation approach in the cooling refrigerating process.
Background technology
In the recent period, freezing preservation cell, sperm, embryo even ovary tissue are successively achieved success, but the freezing preservation of complex organ such as kidney but still is a difficult problem that does not break through as yet.The world today along with the continuous increase of kidney transplant technology rapid development and nephrotic's quantity, presses for a large amount of kidneys and stocks and supply.Clinical transplantation is with supplying kidney all preserving more than 0 ℃ at present, though the method comparative maturity, easy, the holding time is very limited.Though Chinese scholars sets about prolonging the kidney holding time from improving sides such as preserving liquid level and conserving appliance; Or in the limited holding time, improve tissue matching and work; Supply the reasonable utilization rate of kidney and the long-term surviving rate after the transplanting with raising, but still can not satisfy clinical demand.In addition, under the situation that donor organ lacks at home, owing to join type, patient's condition is not inconsistent and reasons such as region also can cause certain organ wasting of resources.Can in a country and even All Around The World scope, share human leucocyte antigen (HLA) (HLA) and join the kidney that type coincide; Make each receptor can both in time obtain optimized confession kidney? For Utopian like this hope; Have only through improving kidney preservation technology; Prolong confession kidney holding time to several months even several years, and set up " organ storehouse " (Organ Bank) and could finally realize.
Summary of the invention
Organ glass freezing according to the invention is preserved liquid; Form by compositions such as dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose, polyethylene glycol; Dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose concentration are 0.1-6mol/L; Polyethylene glycol concentration is 1-20mmol/L, and the pH value scope is 5.0-8.0.Glass freezing is preserved liquid solution in the cooling refrigerating process and is glassy state, does not form ice crystal, avoids or reduce the freezing infringement of cell, can protect cell structure and shape integrity, suppresses histiocytic energy metabolism simultaneously fully.Metabolic activity in cells is restored after suitable means recovery, can bring into play biological function again.Organ glass freezing according to the invention is preserved liquid, can be used for the freezing preservation (200--30 ℃) of kidney, and the long-term frozen that also can be applicable to other organs (liver, heart etc.) is preserved.
Embodiment
To preserve the perfusion kidney through organ glass freezing according to the invention, be cooled to-80 ℃, change profound hypothermia refrigerator or liquid nitrogen long preservation over to.Be warming up to 4 ℃ during the organ recovery, wash-out is preserved laggard line correlation morphology of liquid and function assessment inspection.
Preserve liquid at-80 ℃ of new zealand white rabbit kidneys of preserving for 2 weeks through organ glass freezing according to the invention, general form is not seen obvious freezing infringement, skin medullary substance clear in structure; The interior capillary button loop of glomerulus is complete under the light microscope; The slight swelling of renal cells, ultra microstructures such as glomerular filtration membrane, sertoli cell and mesangial cell are clear under the electron microscope, and the nuclei dyeing chromaticness is dense; Kytoplasm inner cell organ number is normal; Epithelial cell chamber face brush border microvillus marshalling, vascular endothelial cell and elastic membrane are complete, and demonstration kidney tissue morphology after freezing preservation is not seen obvious destruction.
Preserve liquid at-80 ℃ of new zealand white rabbit kidneys of preserving for 2 weeks through organ glass freezing according to the invention; Carry out phenolsulfonphthalein excretion test (PSP test), indicarminum measuring renal tubular function behind the ex vivo perfusion; PSP15 minute and 120 minutes excretion amounts are all near normal value (25%; 55%), sees blue urine at once after the indicarminum perfusion and discharge, show that kidney has the excretion function through freezing preservation metanephric tubule.
Preserve liquid at-80 ℃ of beasle dog kidneys of preserving for 2 weeks through organ glass freezing according to the invention; The autotransplantation of kidney postoperative carried out CDFI, emission single photon computed tomography (ECT) and the inspections such as (IVP) of vein secretion radiography in 1 month; Blood flow passes through in the color ultra visible transplanting kidney, and IVP and ECT show that renal secretion/filtering function continues to exist.

Claims (6)

1. an organ glass freezing is preserved liquid, it is characterized in that, comprises compositions such as dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose, polyethylene glycol.
2. preservation liquid according to claim 1 is characterized in that dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose concentration are 0.1-6mol/L, and polyethylene glycol concentration is 1-20mmol/L, and the pH value scope is 5.0-8.0.
3. requiring 1 described preservation liquid according to economic rights, it is characterized in that, storage temperature is-200--30 degree centigrade.
4. according to the arbitrary described preservation liquid of claim 1 to 3, it is characterized in that described organ is kidney, liver, heart, lungs, skin or limbs etc.
5. an organ store method comprises organ is put into preservation liquid, it is characterized in that, comprises compositions such as dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose, polyethylene glycol in the said preservation liquid.
6. store method according to claim 5 is characterized in that, organ is carried out glass freezing preserve.
CN201010601358.1A 2010-12-23 2010-12-23 Organ vitrificated cryopreserration liquid Active CN102550541B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010601358.1A CN102550541B (en) 2010-12-23 2010-12-23 Organ vitrificated cryopreserration liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010601358.1A CN102550541B (en) 2010-12-23 2010-12-23 Organ vitrificated cryopreserration liquid

Publications (2)

Publication Number Publication Date
CN102550541A true CN102550541A (en) 2012-07-11
CN102550541B CN102550541B (en) 2016-02-17

Family

ID=46398195

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010601358.1A Active CN102550541B (en) 2010-12-23 2010-12-23 Organ vitrificated cryopreserration liquid

Country Status (1)

Country Link
CN (1) CN102550541B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104585165A (en) * 2015-02-24 2015-05-06 陈德琼 Human organ freezing protective solution
CN104904707A (en) * 2015-05-29 2015-09-16 广州赛莱拉干细胞科技股份有限公司 Composition, application of composition, vitrification cryopreserved agent of placenta and preparation method
CN105241726A (en) * 2015-09-14 2016-01-13 黄小军 Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening
CN107236340A (en) * 2017-05-22 2017-10-10 安徽宏远职业卫生技术服务有限公司 A kind of cuvette store method
WO2018118799A1 (en) * 2016-12-20 2018-06-28 Tissue Testing Technologies Llc Ice-free preservation of large volume tissue samples for viable, functional tissue banking
CN111657267A (en) * 2020-06-17 2020-09-15 科瑞百奥泰州生物技术有限公司 Ice-free crystal frozen preservation solution and freezing method for preservation of cartilage, tendon and meniscus
CN117717066A (en) * 2024-02-04 2024-03-19 广东海洋大学 Embryo preservation solution, cryopreservation method thereof and application of embryo preservation solution in cryopreservation of Babylonia embryos

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032225A2 (en) * 2000-10-19 2002-04-25 Organ Recovery Systems Method of cryopreservation of tissues or organs other than a blood vessel by vitrification
CN1986780A (en) * 2006-12-14 2007-06-27 宁夏医学院 New-type of vetrifying solution
CN101037667A (en) * 2007-02-09 2007-09-19 浙江大学 Ultra-low temperature preservation solution for animal cells and preserving method
CN101253856A (en) * 2008-04-11 2008-09-03 中山大学 Vitrification frozen stock solution
WO2010096821A2 (en) * 2009-02-23 2010-08-26 Cell & Tissue Systems, Inc. Method for ice-free cryopreservation of tissue

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032225A2 (en) * 2000-10-19 2002-04-25 Organ Recovery Systems Method of cryopreservation of tissues or organs other than a blood vessel by vitrification
CN1986780A (en) * 2006-12-14 2007-06-27 宁夏医学院 New-type of vetrifying solution
CN101037667A (en) * 2007-02-09 2007-09-19 浙江大学 Ultra-low temperature preservation solution for animal cells and preserving method
CN101253856A (en) * 2008-04-11 2008-09-03 中山大学 Vitrification frozen stock solution
WO2010096821A2 (en) * 2009-02-23 2010-08-26 Cell & Tissue Systems, Inc. Method for ice-free cryopreservation of tissue

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
胡军祥 等: "动物胚胎的玻璃化冻存", 《科技通报》 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104585165A (en) * 2015-02-24 2015-05-06 陈德琼 Human organ freezing protective solution
CN104904707A (en) * 2015-05-29 2015-09-16 广州赛莱拉干细胞科技股份有限公司 Composition, application of composition, vitrification cryopreserved agent of placenta and preparation method
CN105241726A (en) * 2015-09-14 2016-01-13 黄小军 Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening
WO2018118799A1 (en) * 2016-12-20 2018-06-28 Tissue Testing Technologies Llc Ice-free preservation of large volume tissue samples for viable, functional tissue banking
CN110545665A (en) * 2016-12-20 2019-12-06 组织测试技术有限公司 Ice-free preservation of large volume tissue samples for live functional tissue banks
JP2020504725A (en) * 2016-12-20 2020-02-13 ティシュー テスティング テクノロジーズ エルエルシーTissue Testing Technologies Llc Ice-free storage of large volume tissue samples for practical and functional tissue banking
US11246308B2 (en) * 2016-12-20 2022-02-15 Tissue Testing Technologies Llc Ice-free preservation of large volume tissue samples for viable, functional tissue banking
CN107236340A (en) * 2017-05-22 2017-10-10 安徽宏远职业卫生技术服务有限公司 A kind of cuvette store method
CN111657267A (en) * 2020-06-17 2020-09-15 科瑞百奥泰州生物技术有限公司 Ice-free crystal frozen preservation solution and freezing method for preservation of cartilage, tendon and meniscus
CN111657267B (en) * 2020-06-17 2021-02-02 科瑞百奥泰州生物技术有限公司 Ice-free crystal frozen preservation solution and freezing method for preservation of cartilage, tendon and meniscus
CN117717066A (en) * 2024-02-04 2024-03-19 广东海洋大学 Embryo preservation solution, cryopreservation method thereof and application of embryo preservation solution in cryopreservation of Babylonia embryos
CN117717066B (en) * 2024-02-04 2024-04-26 广东海洋大学 Embryo preservation solution, cryopreservation method thereof and application of embryo preservation solution in cryopreservation of Babylonia embryos

Also Published As

Publication number Publication date
CN102550541B (en) 2016-02-17

Similar Documents

Publication Publication Date Title
CN102550541A (en) Organ vitrification freezing and preserving fluid
EP2398316B1 (en) Method for ice-free cryopreservation of tissue
CN102144629A (en) Organ cryopreservation fluid
AU2002211792B2 (en) Method of cryopreservation of tissues or organs other than a blood vessel by vitrification
JP6099808B2 (en) Vitrification freezing carrier of biological sample and use thereof
CN101720753A (en) Cryopreservation solution of tissue engineering products and application method thereof
CN102428911A (en) Cryogenic storing protection liquid for human umbilical cord Wharton's jelly tissue block
Wang et al. Cryopreservation of tissue-engineered dermal replacement in Me2SO: Toxicity study and effects of concentration and cooling rates on cell viability
CN109329271A (en) A kind of clinical mescenchymal stem cell freezen protective liquid and preparation method thereof
CN101971799A (en) Freezing storage protective solution for human umbilical Wharton's jelly tissue block
CN105230610B (en) A kind of freezen protective liquid and its preparation method and application
CN104145943A (en) Cryopreservation protection liquid for Wharton jelly tissues of human umbilical cord and preparation and application of cryopreservation protection liquid
AU2002211792A1 (en) Method of cryopreservation of tissues or organs other than a blood vessel by vitrification
CN104488853A (en) Bovine embryo vitrification freezing tube swinging thawing and direct transplanting method
Wowk How cryoprotectants work
ES2949014T3 (en) Use of a solution comprising PEG for the preservation of stem cells
CN109699636A (en) A kind of glass freezing and defreezing method of embryo
CN104585165A (en) Human organ freezing protective solution
CN115152740A (en) Long-term pig tissue preservation solution and using method thereof
Toner et al. Storage and translational issues in reparative medicine
CN100463963C (en) Freeze preservating method for domestic pig skin tissue
ITPI20000020A1 (en) SACCHAROSE OONCENTRATIONS AND DURATION OF THE EXPOSURE OF THE Oocyte LOADING SOLUTIONS IN THE CRYOPRESERVATION PROCEDURE
CN103355285B (en) Cryopreservation method of tobacco leaf callus cell
CN103348968A (en) Ice-temperature storage method of transplanted kidney and organs
CN111374123A (en) Use method of neutral amino acid as cell cryoprotectant and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice

Addressee: Pan Feng

Document name: the First Notification of an Office Action

DD01 Delivery of document by public notice

Addressee: Liu Di

Document name: Notification to Go Through Formalities of Registration

C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Pan Feng

Document name: Notification of Passing Examination on Formalities